EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment

Yuecen Ding iD, Zhongyi Xu iD, Leihong Flora Xiang iD, Chengfeng Zhang iD

Pigment Cell & Melanoma Research · 2023-11 · 36 (6) · 455-467

DOI: 10.1111/pcmr.13108 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Pigment Cell & Melanoma Research, online erschienen am 04.07.2023. Verfasst von Yuecen Ding und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China. Hauptthemen laut MEDLINE: Tranexamic Acid, Melanosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 75 Literaturangaben. Gefördert von: Medical innovation re-search special project of Shanghai Science and Technology Commission, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Riehl's melanosis is a hyperpigmentation disorder that has a significant psychological and social impact on individuals. In the past 10 years, new categories have been developed, raising questions about how to classify Riehl's melanosis. The mechanism of this disease remains unclear, although the type IV hypersensitivity response caused by allergic sensitization, as well as genetic, ultraviolet radiation, and autoimmune factors, is to blame. Clinical manifestation, dermoscopy, reflectance confocal microscopy, patch/photopatch testing, histopathology, and a novel multimodality skin imaging system have been used for the diagnosis. A variety of therapies including topical skin‐lightening agents, oral tranexamic acid, glycyrrhizin compound, chemical peels, and lasers and light therapies (intense pulsed light, 1064‐nm Q‐Switched Nd: YAG laser, 755‐nm PicoWay laser, nonablative 1927‐nm fractional thulium fiber laser, new pulsed‐type microneedling radiofrequency), with improved effectiveness. The latest findings on possible biomarkers and their relationship to other autoimmune diseases were also summarized.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Tranexamic AcidMelanosisHumansUltraviolet RaysSkinGlycyrrhizic AcidTreatment Outcome

Stichwörter der Autor:innen

diagnosisetiologyhyperpigmentationmelanosistherapy

Substanzen

Tranexamic AcidGlycyrrhizic Acid

Autor:innen und Institutionen

  • Department of Dermatology, Huashan Hospital, Fudan University, Shanghai, China.

ORCID-Profile: Yuecen Ding, Zhongyi Xu, Leihong Flora Xiang, Chengfeng Zhang

Förderung

  • Medical innovation re-search special project of Shanghai Science and Technology Commission
  • National Natural Science Foundation of China

Zitieren

APA

Ding, Y., Xu, Z., Xiang, L. F., & Zhang, C. (2023). Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment. Pigment Cell & Melanoma Research, 36(6), 455-467. https://doi.org/10.1111/pcmr.13108

Vancouver

Ding Y, Xu Z, Xiang LF, Zhang C. Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment. Pigment Cell & Melanoma Research. 2023;36(6):455-467. doi:10.1111/pcmr.13108

BibTeX
@article{Ding2023,
  author = {Ding, Yuecen and Xu, Zhongyi and Xiang, Leihong Flora and Zhang, Chengfeng},
  title = {Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment},
  journal = {Pigment Cell & Melanoma Research},
  year = {2023},
  volume = {36},
  number = {6},
  pages = {455--467},
  doi = {10.1111/pcmr.13108}
}
Kostenlos starten →